SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:liu-116664"
 

Sökning: onr:"swepub:oai:DiVA.org:liu-116664" > The WAP four-disulf...

  • de Boer, Rudolf AUniversity of Groningen, the Netherlands (författare)

The WAP four-disulfide core domain protein HE4 : a novel biomarker for heart failure.

  • Artikel/kapitelEngelska2013

Förlag, utgivningsår, omfång ...

  • Elsevier BV,2013
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:liu-116664
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-116664URI
  • https://doi.org/10.1016/j.jchf.2012.11.005DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • OBJECTIVES: This study investigated clinical determinants and added prognostic value of HE4 as a biomarker not previously described in heart failure (HF).BACKGROUND: Identification of plasma biomarkers that help to risk stratify HF patients may help to improve treatment.METHODS: Plasma HE4 levels were determined in 567 participants of the COACH (Coordinating study evaluating outcomes of Advising and Counseling in Heart failure). Patients had been hospitalized for HF and were followed for 18 months. The primary endpoint of this study was a composite of all-cause mortality and HF hospitalization.RESULTS: HE4 showed a strong correlation with HF severity, according to New York Heart Association functional class and brain natriuretic peptide (BNP) levels (p < 0.001). HE4 also showed a positive correlation with GDF15 (p < 0.001) and, in addition, correlated with kidney function (estimated glomerular filtration rate [eGFR]; p < 0.001). Cox regression analysis revealed that a doubling of HE4 levels was associated with a hazard ratio (HR) of 1.73 (95% confidence interval [CI]: 1.53 to 1.95) for the primary outcome (p < 0.001). After correction for age, gender, BNP, and eGFR, the HR was 1.46 (95% CI: 1.23 to 1.72; p < 0.001), and after additional adjustment for GDF15, the HR lowered to 1.30 (95% CI: 1.07 to 1.59; p = 0.009). The area under the curve in the receiver-operating characteristic curve analysis increased from 0.727 to 0.752 when HE4 was included in the clinical evaluation (p = 0.051). The integrated discrimination improvement and net reclassification index for reclassification showed significant improvements when HE4 was added to the clinical model, and this remained significant after BNP inclusion in the model.CONCLUSIONS: HE4 plasma levels are correlated with markers of HF severity, show prognostic value, and can improve risk assessment in HF.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Cao, QiUniversity of Groningen, the Netherlands (författare)
  • Postmus, DouweUniversity of Groningen, the Netherlands (författare)
  • Damman, KevinUniversity of Groningen, the Netherlands (författare)
  • Voors, Adriaan AUniversity of Groningen, the Netherlands (författare)
  • Jaarsma, TinyLinköpings universitet,Hälsa, Aktivitet, Vård (HAV),Hälsouniversitetet(Swepub:liu)tinja77 (författare)
  • van Veldhuisen, Dirk JUniversity of Groningen, the Netherlands (författare)
  • Arnold, William DAlere San Diego, Inc., San Diego, California (författare)
  • Hillege, Hans LUniversity of Groningen, the Netherlands (författare)
  • Silljé, Herman H WUniversity of Groningen, the Netherlands (författare)
  • University of Groningen, the NetherlandsHälsa, Aktivitet, Vård (HAV) (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:JACC. Heart failure: Elsevier BV1:2, s. 164-1692213-17872213-1779

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy